Compounds > 2-chloro-n(6)cyclopentyladenosine
Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and gsk0660

2-chloro-n(6)cyclopentyladenosine has been researched along with gsk0660 in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)		Trials
(2-chloro-n(6)cyclopentyladenosine)		Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)		Studies
(gsk0660)		Trials
(gsk0660)		Recent Studies (post-2010) (gsk0660)
25204355045

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)gsk0660 (IC50)
Peroxisome proliferator-activated receptor deltaMus musculus (house mouse)0.048
Peroxisome proliferator-activated receptor deltaHomo sapiens (human)0.2099

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and gsk0660

ArticleYear
Polypharmacology of N
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3

2017